JLE

European Journal of Dermatology

MENU

Journal club: Bullous pemphigoid Volume 32, issue 1, January-February 2022

Authors
1 Department of Dermatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
2 CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; Ecole Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France; Department of Dermatology and Allergology, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest-en-Jarez, France
3 Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
4 Dermatology of Department, Cambridge University Hospitals, Addenbrookes Hospital, Cambridge, UK
5 Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal
6 Department of Dermatology, Hospital General Universitario Gregorio Mara˜nón, Madrid, Spain

Bullous pemphigoid (BP) is a common autoimmune blistering disease. It is characterised by the presence of circulating autoantibodies against different components of the hemidesmosomes such as BP180 or BP230, causing the formation of subepidermal blisters. BP typically affects people over the age of 50 and usually presents with pruritic urticarial plaques and tense blisters frequently located on the trunk and limbs; mucosal involvement is infrequent [1]. Reports published over the last few years indicate [...]